Latest in Clinical trials

  • At ADA, JDRF-Funded Research Takes Center Stage (featuring a “Happy Hour” with Dr. Aaron Kowalski)

    June 17, 2020

    At the American Diabetes Association’s Scientific Sessions, which was held virtually from June 12-16, scientists presented on some of the most important...

  • Dr. Jane Buckner Discusses Hydroxychloroquine T1D Prevention Study

    May 28, 2020

    Details about the TrialNet study, including why Hydroxychloroquine, and the status of subject participation.

  • Advancing Cures with Type 1 Diabetes Clinical Trials

    May 20, 2020

    JDRF funds type 1 diabetes (T1D) clinical trials that are critical to bringing new devices and treatments to people with this disease....

  • At the Front Lines in COVID-19: JDRF-Funded Scientist’s Company Developing a Vaccine

    April 29, 2020

    With coronavirus closing schools and forcing so many people to stay inside or wear facemasks every time they step outdoors, COVID-19 is...

  • National DNA Day!

    April 24, 2020

    JDRF is honored to celebrate National DNA Day, to commemorate the day in 1953 when the structure of DNA was published. We...

  • Zucara Faces "Valley of Death," and Comes Out Triumphant

    April 2, 2020

    Low blood sugar, called hypoglycemia, is a real fear for people with type 1 diabetes (T1D). Although there are rescue treatments for...

  • JDRF Awards World-Renowned T1D Researchers

    February 4, 2020

    JDRF is honored to recognize five leading international researchers whose work has and is transforming type 1 diabetes (T1D) science. We also...

  • Universal Screening for Type 1 Diabetes: Its Time has Come?

    January 28, 2020

    Universal screening for type 1 diabetes (T1D) is a priority for JDRF, but the cost versus benefits remain unclear. Now, a large-scale...

  • Can Prozac Prevent Severe Low Blood Sugar?

    January 13, 2020

    Low blood sugar, called hypoglycemia, occurs in over 90 percent of people with type 1 diabetes (T1D). It can usually be detected...

  • The Promising Clinical Trials in the JDRF Pipeline

    December 9, 2019

    As the leading global funder of type 1 diabetes (T1D) research, JDRF invests in the most promising research studies across the world—including...